Last 12 months
Inside the activity.
22 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 6 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 10 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 6 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2023 Filed Mar 9, 2023 01:15 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Tax withholdingCommon Stock | 672 | $58.13 | $39,063.36 |
DisclosureSEC source: 0001209191-23-017419 · doc4.xml · nonDerivative · entry 1 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,236 Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 21:06 UTC |
FRINZI THOMAS GDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 160,638 | $0.00 Strike: $51.25 | $0.00 |
DisclosureSEC source: 0001209191-23-000847 · doc4.xml · derivative · entry 2 FRINZI THOMAS G · CIK 0001663458 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,638 Underlying: Common Stock · 160,638 shares Expires 2033-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 1/3/2024 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 1/3/2026. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 21:06 UTC |
FRINZI THOMAS GDirector · President & CEO
|
Exercise / conversionCommon Shares | 87,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-000847 · doc4.xml · nonDerivative · entry 1 FRINZI THOMAS G · CIK 0001663458 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Award of 87,805 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 29,268 of the RSUs on 1/3/24, 29,268 of the RSUs on 1/3/25, and 29,269 of the RSUs on 1/3/26. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 21:08 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock Options · Derivative | 19,139 | $0.00 Strike: $48.54 | $0.00 |
DisclosureSEC source: 0001209191-23-000858 · doc4.xml · derivative · entry 1 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,139 Underlying: Common Stock · 19,139 shares Expires 2032-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 12/30/2023 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 12/30/2025. Read SEC document |
| December 29, 2022 Filed Dec 29, 2022 23:26 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
PurchaseCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-22-007188 · ownership.xml · nonDerivative · entry 6 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote Disclosed balance after: 8,783,082 F1 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| December 29, 2022 Filed Dec 29, 2022 23:26 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
PurchaseCommon Stock | 39,090 | $47.93 | $1,873,431.25 |
DisclosureSEC source: 0000919574-22-007188 · ownership.xml · nonDerivative · entry 5 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,783,082 F4 · price: This constitutes the weighted average purchase price. The prices range from $47.78 to $47.99. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. F1 · ownership.direct: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| December 28, 2022 Filed Dec 29, 2022 23:26 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
PurchaseCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-22-007188 · ownership.xml · nonDerivative · entry 4 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote Disclosed balance after: 8,743,992 F1 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| December 28, 2022 Filed Dec 29, 2022 23:26 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
PurchaseCommon Stock | 100,000 | $46.98 | $4,697,610.00 |
DisclosureSEC source: 0000919574-22-007188 · ownership.xml · nonDerivative · entry 3 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,743,992 F3 · price: This constitutes the weighted average purchase price. The prices range from $46.38 to $48.185. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. F1 · ownership.direct: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| December 27, 2022 Filed Dec 29, 2022 23:26 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
PurchaseCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-22-007188 · ownership.xml · nonDerivative · entry 2 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote Disclosed balance after: 8,643,992 F1 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| December 27, 2022 Filed Dec 29, 2022 23:26 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
PurchaseCommon Stock | 51,985 | $47.91 | $2,490,533.77 |
DisclosureSEC source: 0000919574-22-007188 · ownership.xml · nonDerivative · entry 1 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,643,992 F2 · price: This constitutes the weighted average purchase price. The prices range from $47.32 to $48.19. The Reporting Person will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. F1 · ownership.direct: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| September 27, 2022 Filed Sep 29, 2022 20:27 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock Options · Derivative | 13,075 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001209191-22-051533 · doc4.xml · derivative · entry 5 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,075 shares Expires 2026-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2022 Filed Sep 29, 2022 20:27 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
SaleCommon Stock | 13,075 | $75.00 | $980,625.00 |
DisclosureSEC source: 0001209191-22-051533 · doc4.xml · nonDerivative · entry 4 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,908 Read SEC document |
| September 27, 2022 Filed Sep 29, 2022 20:27 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
Exercise / conversionCommon Stock | 13,075 | $7.52 | $98,324.00 |
DisclosureSEC source: 0001209191-22-051533 · doc4.xml · nonDerivative · entry 3 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2022 Filed Sep 29, 2022 20:27 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
SaleCommon Stock | 15,683 | $75.00 | $1,176,225.00 |
DisclosureSEC source: 0001209191-22-051533 · doc4.xml · nonDerivative · entry 2 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,908 Read SEC document |
| September 27, 2022 Filed Sep 29, 2022 20:27 UTC |
Francese James ESr. VP, Comm. Ops., NA, APAC
|
SaleCommon Stock | 6,667 | $75.00 | $500,025.00 |
DisclosureSEC source: 0001209191-22-051533 · doc4.xml · nonDerivative · entry 1 Francese James E · CIK 0001571478 · Sr. VP, Comm. Ops., NA, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,591 Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:26 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 9,388 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001209191-22-046265 · doc4.xml · derivative · entry 8 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,388 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:26 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 1,499 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-22-046265 · doc4.xml · derivative · entry 7 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,499 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:26 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock Options · Derivative | 695 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-22-046265 · doc4.xml · derivative · entry 6 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 695 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:26 UTC |
Holliday KeithChief Technology Officer
|
SaleCommon Stock | 5,000 | $106.22 | $531,100.00 |
DisclosureSEC source: 0001209191-22-046265 · doc4.xml · nonDerivative · entry 5 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,437 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.66 to $110.20, inclusive. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:26 UTC |
Holliday KeithChief Technology Officer
|
SaleCommon Stock | 11,582 | $106.32 | $1,231,398.24 |
DisclosureSEC source: 0001209191-22-046265 · doc4.xml · nonDerivative · entry 4 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,347 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.51 to $110.88, inclusive. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:26 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 9,388 | $35.98 | $337,780.24 |
DisclosureSEC source: 0001209191-22-046265 · doc4.xml · nonDerivative · entry 3 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:26 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 1,499 | $29.80 | $44,670.20 |
DisclosureSEC source: 0001209191-22-046265 · doc4.xml · nonDerivative · entry 2 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:26 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 695 | $16.15 | $11,224.25 |
DisclosureSEC source: 0001209191-22-046265 · doc4.xml · nonDerivative · entry 1 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:42 UTC |
Yu K PeonyDirector
|
Exercise / conversionCommon Stock Options · Derivative | 5,765 | $0.00 Strike: $62.10 | $0.00 |
DisclosureSEC source: 0001209191-22-038111 · doc4.xml · derivative · entry 2 Yu K Peony · CIK 0001621328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,765 Underlying: Common Stock · 5,765 shares Expires 2033-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to her continued service through the vesting date. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:42 UTC |
Yu K PeonyDirector
|
Exercise / conversionCommon Stock | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038111 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:41 UTC |
Lin Elizabeth YeuDirector
|
Exercise / conversionCommon Stock Options · Derivative | 5,765 | $0.00 Strike: $61.10 | $0.00 |
DisclosureSEC source: 0001209191-22-038107 · doc4.xml · derivative · entry 2 Lin Elizabeth Yeu · CIK 0001842190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,765 Underlying: Common Stock · 5,765 shares Expires 2032-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to her continued service through the vesting date. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:41 UTC |
Lin Elizabeth YeuDirector
|
Exercise / conversionCommon Stock | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038107 · doc4.xml · nonDerivative · entry 1 Lin Elizabeth Yeu · CIK 0001842190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:40 UTC |
Kliman Gilbert HDirector
|
Exercise / conversionCommon Stock | 2,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038104 · doc4.xml · nonDerivative · entry 2 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The restrictions on the 2899 restricted shares of common stock awarded on his re-election to the Board of Directors lapse on the earlier of June 16, 2023 or the Corporation's 2023 Annual Meeting, subject to his continued service through that date. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:40 UTC |
Kliman Gilbert HDirector
|
Exercise / conversionCommon Stock | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038104 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:35 UTC |
FRINZI THOMAS GDirector
|
Exercise / conversionCommon Stock Options · Derivative | 2,881 | $0.00 Strike: $62.10 | $0.00 |
DisclosureSEC source: 0001209191-22-038095 · doc4.xml · derivative · entry 3 FRINZI THOMAS G · CIK 0001663458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,881 Underlying: Common Stock · 2,881 shares Expires 2032-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to his continued service through the vesting date. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:35 UTC |
FRINZI THOMAS GDirector
|
Exercise / conversionCommon Stock | 1,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038095 · doc4.xml · nonDerivative · entry 2 FRINZI THOMAS G · CIK 0001663458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The restricted shares vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to his continued service through the vesting date. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:35 UTC |
FRINZI THOMAS GDirector
|
Exercise / conversionCommon Stock | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038095 · doc4.xml · nonDerivative · entry 1 FRINZI THOMAS G · CIK 0001663458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:32 UTC |
FARRELL STEPHEN CDirector
|
Exercise / conversionCommon Stock Options · Derivative | 5,765 | $0.00 Strike: $62.10 | $0.00 |
DisclosureSEC source: 0001209191-22-038092 · doc4.xml · derivative · entry 2 FARRELL STEPHEN C · CIK 0001188757 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,765 Underlying: Common Stock · 5,765 shares Expires 2032-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to his continued service through the vesting date. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:32 UTC |
FARRELL STEPHEN CDirector
|
Exercise / conversionCommon Stock | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038092 · doc4.xml · nonDerivative · entry 1 FARRELL STEPHEN C · CIK 0001188757 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:31 UTC |
WEISNER AIMEE SDirector
|
Exercise / conversionCommon Stock Options · Derivative | 5,765 | $0.00 Strike: $62.10 | $0.00 |
DisclosureSEC source: 0001209191-22-038087 · doc4.xml · derivative · entry 1 WEISNER AIMEE S · CIK 0001227308 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,765 Underlying: Common Stock · 5,765 shares Expires 2032-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to her continued service through the vesting date. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 21:46 UTC |
Williams Patrick F.Chief Financial Officer
|
Exercise / conversionCommon Stock | 5,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035145 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 6, 2022 20:31 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 6,191 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-22-034528 · doc4.xml · derivative · entry 8 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,809 Underlying: Common Stock · 6,191 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 6, 2022 20:31 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 14,765 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-22-034528 · doc4.xml · derivative · entry 7 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,235 Underlying: Common Stock · 14,765 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 6, 2022 20:31 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 34,928 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001209191-22-034528 · doc4.xml · derivative · entry 6 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,072 Underlying: Common Stock · 34,928 shares Expires 2026-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 6, 2022 20:31 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 12,886 | $0.00 Strike: $7.76 | $0.00 |
DisclosureSEC source: 0001209191-22-034528 · doc4.xml · derivative · entry 5 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,114 Underlying: Common Stock · 12,886 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 6, 2022 20:31 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock | 6,191 | $16.15 | $99,984.65 |
DisclosureSEC source: 0001209191-22-034528 · doc4.xml · nonDerivative · entry 4 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 6, 2022 20:31 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock | 14,765 | $9.30 | $137,314.50 |
DisclosureSEC source: 0001209191-22-034528 · doc4.xml · nonDerivative · entry 3 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 6, 2022 20:31 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock | 34,928 | $7.52 | $262,658.56 |
DisclosureSEC source: 0001209191-22-034528 · doc4.xml · nonDerivative · entry 2 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 6, 2022 20:31 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,886 | $7.76 | $99,995.36 |
DisclosureSEC source: 0001209191-22-034528 · doc4.xml · nonDerivative · entry 1 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2022 Filed May 20, 2022 22:30 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 35,000 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-22-031137 · doc4.xml · derivative · entry 9 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 35,000 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2022 Filed May 20, 2022 22:30 UTC |
Mason Caren LDirector · President & CEO
|
SaleCommon Stock | 35,000 | $58.48 | $2,046,800.00 |
DisclosureSEC source: 0001209191-22-031137 · doc4.xml · nonDerivative · entry 6 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,645 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.16 to $60.62. Read SEC document |
| May 20, 2022 Filed May 20, 2022 22:30 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock | 35,000 | $9.30 | $325,500.00 |
DisclosureSEC source: 0001209191-22-031137 · doc4.xml · nonDerivative · entry 5 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2022 Filed May 20, 2022 22:30 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock Options · Derivative | 35,000 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-22-031137 · doc4.xml · derivative · entry 8 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 35,000 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2022 Filed May 20, 2022 22:30 UTC |
Mason Caren LDirector · President & CEO
|
SaleCommon Stock | 35,000 | $57.49 | $2,012,150.00 |
DisclosureSEC source: 0001209191-22-031137 · doc4.xml · nonDerivative · entry 4 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,645 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.89 to $58.15. Read SEC document |
| May 19, 2022 Filed May 20, 2022 22:30 UTC |
Mason Caren LDirector · President & CEO
|
Exercise / conversionCommon Stock | 35,000 | $9.30 | $325,500.00 |
DisclosureSEC source: 0001209191-22-031137 · doc4.xml · nonDerivative · entry 3 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.